Pack in or go on: Topographic disorientation induced by bupropion sustained release tablet

ISSN: 2147-0634
Yayın Aralığı: Yılda 4 Sayı
Başlangıç: 2012
Yayıncı: Effect Publishing Agency ( EPA )

The mechanism of effect of bupropion is unknown. The authors report a case of bupropion-associated topographic disorientation during bupropion treatment for smoking cessation. A 44-year-old female patient with a history not knowing where she is, the inability to recognize the surrounding buildings was admitted to neurology department. During her admission, her symptoms disappeared and she did not continue her medication. There was no abnormality in the investigation. It was concluded that the onset of symptoms was dose dependent. Bupropion may cause unusual neuropsychiatric behaviors. This case suggests that topographic disorientation may be the primary symptom of bupropion toxicity.

PDF

___

1. Fava M, Rush AJ, Thase ME, et al. 15 Years of clinical experience with bupropion HCl: From bupropion to bupropion SR to bupropion XL. Prim Care Companion J Clin Psy-chiatry. 2005;7:106-13.

2. Settle EC Jr. Bupropion sustained release: side effect profile. J Clin Psychiatry. 1998;59 Suppl 4:32-6.

3. Bottini G, Cappa S, Geminiani G, et al. Topographic disorientation--a case report. Neuropsychologia. 1990;28:309–12.

4. Skripuletz T, Garde N, Vidal C, et al. Bupropion-induced status epilepticus and retro-grade amnesia. J Neuropsychiatry Clin Neurosci. 2010;22:123.9.

5. Humma LM, Swims MP. Bupropion mimics a transient ischemic attack. Ann Pharma-cother. 1999;33:305-7.

6. Preskorn SH. Should bupropion dosage be adjusted based upon therapeutic drug monitoring? Psychopharmacol Bull. 1991;27:637–43.

7. Dager SR, Heritch AJ. A case of bupropion-associated delirium. J Clin Psychiatry. 1990;51:307-8.